Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Light

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Clinical Neuropharmacology|August 3, 2005
Efficacy and tolerability of low-dose donepezil in schizophreniaSteven K Erickson, Steven B Schwarzkopf, Donna Palumbo, et al.
Psychiatry and Clinical Neurosciences|January 20, 2021
Source decomposition of the frontocentral auditory steady-state gamma band response in schizophrenia patients and healthy subjectsDaisuke Koshiyama, Makoto Miyakoshi, Yash B Joshi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2016
Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated TaskJared W Young, Andrew W Bismark, Yinming Sun, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 25, 2019
Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patientsNeal R Swerdlow, Savita G Bhakta, Jo Talledo, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|January 16, 2021
Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjectsDaisuke Koshiyama, Makoto Miyakoshi, Yash B Joshi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 25, 2015
GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric DisordersJared W Young, Mary E Kamenski, Kerin K Higa, et al.
Psychopharmacology|June 16, 2012
Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in ratsNeal R Swerdlow, Paul D Shilling, Michelle Breier, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 23, 2012
Older patients with schizophrenia: does military veteran status matter?Steven R Thorp, Heather M Sones, Danielle Glorioso, et al.
Journal of Abnormal Psychology|March 10, 2017
Evidence of systematic attenuation in the measurement of cognitive deficits in schizophreniaMichael L Thomas, Virginie M Patt, Andrew Bismark, et al.
Psychophysiology|February 17, 2025
Impact of ERP Reliability Cutoffs on Sample Characteristics and Effect Sizes: Performance-Monitoring ERPs in Psychosis and Healthy ControlsGavin Heindorf, Amanda Holbrook, Bohyun Park, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Clinical Neuropharmacology|August 3, 2005
Efficacy and tolerability of low-dose donepezil in schizophreniaSteven K Erickson, Steven B Schwarzkopf, Donna Palumbo, et al.
Psychiatry and Clinical Neurosciences|January 20, 2021
Source decomposition of the frontocentral auditory steady-state gamma band response in schizophrenia patients and healthy subjectsDaisuke Koshiyama, Makoto Miyakoshi, Yash B Joshi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 6, 2016
Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated TaskJared W Young, Andrew W Bismark, Yinming Sun, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 25, 2019
Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patientsNeal R Swerdlow, Savita G Bhakta, Jo Talledo, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|January 16, 2021
Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjectsDaisuke Koshiyama, Makoto Miyakoshi, Yash B Joshi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 25, 2015
GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric DisordersJared W Young, Mary E Kamenski, Kerin K Higa, et al.
Psychopharmacology|June 16, 2012
Fronto-temporal-mesolimbic gene expression and heritable differences in amphetamine-disrupted sensorimotor gating in ratsNeal R Swerdlow, Paul D Shilling, Michelle Breier, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 23, 2012
Older patients with schizophrenia: does military veteran status matter?Steven R Thorp, Heather M Sones, Danielle Glorioso, et al.
Journal of Abnormal Psychology|March 10, 2017
Evidence of systematic attenuation in the measurement of cognitive deficits in schizophreniaMichael L Thomas, Virginie M Patt, Andrew Bismark, et al.
Psychophysiology|February 17, 2025
Impact of ERP Reliability Cutoffs on Sample Characteristics and Effect Sizes: Performance-Monitoring ERPs in Psychosis and Healthy ControlsGavin Heindorf, Amanda Holbrook, Bohyun Park, et al.
Pageof 18